Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masakazu Komatsu
AK106-001616, a Potent and Selective Inhibitor of Cytosolic Phospholipase A2: In Vivo Efficacy for Inflammation, Neuropathic Pain, and Pulmonary Fibrosis
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Comparison Between the Internal and External Pressure Filtration Method of Cell‐free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites
Therapeutic Apheresis and Dialysis
Hematology
Nephrology
Related publications
Selective Deletion of Group v Phospholipase A2 in Macrophages Reduces Alternaria-Induced Pulmonary Inflammation
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Correction to “Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A2 (GIVA cPLA2)”
ACS Omega
Chemistry
Chemical Engineering
HIV-1 and Alcohol Abuse Promote Astrocyte Inflammation: A Mechanistic Synergy via the Cytosolic Phospholipase A2 Pathway
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Molecular Characterization of Cytosolic Phospholipase A2-Β
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cytosolic Phospholipase A2 Modulates TLR2 Signaling in Synoviocytes
PLoS ONE
Multidisciplinary
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and in Vivo Characterization
Molecular Cancer Therapeutics
Cancer Research
Oncology
The First Potent Inhibitor of Mammalian Group X Secreted Phospholipase A2: Elucidation of Sites for Enhanced Binding
Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and StructureActivity Relationships
Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and StructureActivity Relationships
